More than 54 months survival of a patient with lung adenocarcinoma after maintenance therapy with pemetrexed

J BUON. 2010 Oct-Dec;15(4):797.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / mortality
  • Adenocarcinoma of Lung
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Glutamates / therapeutic use*
  • Guanine / analogs & derivatives*
  • Guanine / therapeutic use
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / mortality
  • Pemetrexed
  • Survival Rate
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Glutamates
  • Pemetrexed
  • Guanine